Business
This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more...
MindMed Launches DMT Clinical Trial! Joe Rogan must be excited! In this episode, we'll discuss MindMed 's (NASDAQ: MNMD), (...
The global supply chain of regulated psilocybin and ibogaine continues to grow as these Canadian companies beef up manufacturing efforts....
What's up Psychedelic Investors? We all know that MindMed (MNMD / MMED) has been talking about eventually finding partners in...
There is currently no known cure for the disease affecting 10 million people worldwide, but this psychedelics company thinks it...
Big Week For Psychedelic Stocks: Field Trip Uplists to Nasdaq, Cybin Uplists to NYSE & Mydecine Files A NEW MDMA...
This week in psychedelic business news: Psychedelics as a treatment for obesity and TBIs, plus another psychedelic company inches toward...
And in other psychedelic stock news, Origin Therapeutics launches to make equity investments in emerging psychedelics-related companies....
The mental healthcare crisis is escalating: Are Psychedelic Medicines the Solution? Can psychedelics health North America fight against anxiety, depression...
Fungi bioscience company describes the project as “one of the most robust genetics research initiatives in the emerging psychedelics space...